Avastin (bevacizumab): Process for Removal of Breast Cancer Indication Begun

Audience: Oncology, Patients ISSUE: FDA notified healthcare professionals and patients that it is recommending removing the breast cancer indication for Avastin (bevacizumab) because the drug has not been shown to be safe and effective for that use….



No related posts.